| 000 | 01344 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514015450.0 | ||
| 264 | 0 | _c20020117 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0145-6008 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoistinen, M | |
| 245 | 0 | 0 |
_aNaltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. _h[electronic resource] |
| 260 |
_bAlcoholism, clinical and experimental research _cNov 2001 |
||
| 300 |
_a1605-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 |
_aCorpus Striatum _xchemistry |
| 650 | 0 | 4 |
_aDopamine _xanalysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthanol _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaltrexone _xpharmacology |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xanalysis |
| 650 | 0 | 4 |
_aNucleus Accumbens _xchemistry |
| 650 | 0 | 4 |
_aOxidopamine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSelf Administration |
| 650 | 0 | 4 |
_aSerotonin _xanalysis |
| 650 | 0 | 4 |
_aSympatholytics _xpharmacology |
| 700 | 1 | _aTuomainen, P | |
| 700 | 1 | _aHyytiä, P | |
| 700 | 1 | _aKiianmaa, K | |
| 773 | 0 |
_tAlcoholism, clinical and experimental research _gvol. 25 _gno. 11 _gp. 1605-12 |
|
| 999 |
_c11622523 _d11622523 |
||